John P. Lamond

1.4k total citations
29 papers, 994 citations indexed

About

John P. Lamond is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Epidemiology. According to data from OpenAlex, John P. Lamond has authored 29 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 6 papers in Epidemiology. Recurrent topics in John P. Lamond's work include Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Prostate Cancer Treatment and Research (7 papers). John P. Lamond is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Prostate Cancer Treatment and Research (7 papers). John P. Lamond collaborates with scholars based in United States. John P. Lamond's co-authors include Timothy J. Kinsella, R M Auchter, William Noyes, Allan B. Levin, Minesh P. Mehta, Luther W. Brady, Rachelle Lanciano, Jun Yang, Rick Chappell and Jay S. Loeffler and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and Medical Physics.

In The Last Decade

John P. Lamond

27 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Lamond United States 14 798 449 279 274 258 29 994
Banu Atalar Türkiye 13 485 0.6× 263 0.6× 201 0.7× 188 0.7× 193 0.7× 64 718
John M. Varlotto United States 21 754 0.9× 252 0.6× 79 0.3× 382 1.4× 433 1.7× 54 1.3k
Kelly Stuhr United States 15 382 0.5× 194 0.4× 216 0.8× 106 0.4× 144 0.6× 25 660
James D. Kolker United States 11 414 0.5× 119 0.3× 190 0.7× 94 0.3× 167 0.6× 20 580
J.H. Heinzerling United States 15 748 0.9× 137 0.3× 501 1.8× 114 0.4× 330 1.3× 56 1.2k
Mark E. Augspurger United States 10 764 1.0× 179 0.4× 481 1.7× 69 0.3× 181 0.7× 15 1.1k
Steve Leibel United States 8 534 0.7× 149 0.3× 286 1.0× 65 0.2× 95 0.4× 10 698
Keith Unger United States 17 373 0.5× 85 0.2× 235 0.8× 136 0.5× 398 1.5× 64 940
L. Trodella Italy 14 469 0.6× 122 0.3× 86 0.3× 105 0.4× 353 1.4× 58 826
A. Yuriko Minn United States 13 275 0.3× 130 0.3× 167 0.6× 54 0.2× 193 0.7× 18 636

Countries citing papers authored by John P. Lamond

Since Specialization
Citations

This map shows the geographic impact of John P. Lamond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Lamond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Lamond more than expected).

Fields of papers citing papers by John P. Lamond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Lamond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Lamond. The network helps show where John P. Lamond may publish in the future.

Co-authorship network of co-authors of John P. Lamond

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Lamond. A scholar is included among the top collaborators of John P. Lamond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Lamond. John P. Lamond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Jing, Alicia Lozano, Alexandra Hanlon, et al.. (2020). Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations. Advances in Radiation Oncology. 5(5). 984–993. 10 indexed citations
2.
Lanciano, Rachelle, Jing Feng, Alexandra L. Hanlon, et al.. (2020). Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experience With Long-Term Follow-Up. Frontiers in Oncology. 10. 1505–1505. 1 indexed citations
4.
Oliai, Caspian, Luther W. Brady, Jun Yang, et al.. (2016). Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer. Journal of Radiation Oncology. 5(2). 187–195. 10 indexed citations
5.
Brown, Doris, Rachelle Lanciano, Jun Yang, et al.. (2016). The effect of whole-brain radiation (WBI) and Karnofsky performance status (KPS) on survival of patients receiving stereotactic radiosurgery (SRS) for second brain metastatic event. Journal of Radiation Oncology. 6(1). 31–37. 3 indexed citations
6.
Lanciano, Rachelle, Alexandra L. Hanlon, Jun Yang, et al.. (2016). The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups. Frontiers in Oncology. 6. 184–184. 13 indexed citations
7.
Hasan, Shaakir, Rachelle Lanciano, Alexandra L. Hanlon, et al.. (2016). Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation Therapy. Frontiers in Oncology. 6. 249–249. 27 indexed citations
8.
Hasan, Shaakir, Rachelle Lanciano, Jun Yang, et al.. (2015). Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience. Frontiers in Oncology. 5. 106–106. 27 indexed citations
9.
Lamond, John P., Michael K. Wong, Rachelle Lanciano, et al.. (2015). Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting. Frontiers in Oncology. 5. 146–146. 13 indexed citations
10.
Patel, Nisha R., Rachelle Lanciano, K. Sura, et al.. (2014). Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses. Journal of Radiation Oncology. 4(1). 65–70. 38 indexed citations
11.
Oliai, Caspian, Rachelle Lanciano, Alexandra L. Hanlon, et al.. (2014). SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines. Frontiers in Oncology. 4. 312–312. 25 indexed citations
12.
Yang, Jun, et al.. (2014). SU‐E‐T‐11: A Dosimetric Comparison of Robotic Prostatic Radiosugery Using Multi‐ Leaf Collimation Vs Circular Collimators. Medical Physics. 41(6Part11). 223–224. 1 indexed citations
13.
Oliai, Caspian, Rachelle Lanciano, Jun Yang, et al.. (2012). Stereotactic body radiation therapy for the primary treatment of localized prostate cancer. Journal of Radiation Oncology. 2(1). 63–70. 61 indexed citations
14.
Garber, Bruce B., et al.. (2010). Acute Toxicity After CyberKnife-Delivered Hypofractionated Radiotherapy for Treatment of Prostate Cancer. American Journal of Clinical Oncology. 34(1). 6–10. 33 indexed citations
15.
Yang, Jun, Jack F. Fowler, John P. Lamond, et al.. (2010). Red Shell: Defining a High-Risk Zone of Normal Tissue Damage in Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 77(3). 903–909. 29 indexed citations
16.
Larson, Paul O., Stephen Nychay, Stephen N. Snow, et al.. (1998). Angiosarcoma of the Head and Neck Managed by a Combination of Multiple Biopsies to Determine Tumor Margin and Radiation Therapy. Dermatologic Surgery. 24(10). 1105–1110. 21 indexed citations
17.
Mehta, Minesh P., William Noyes, John P. Lamond, et al.. (1997). A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. International Journal of Radiation Oncology*Biology*Physics. 39(2). 445–454. 138 indexed citations
18.
Lamond, John P., Meizhi Wang, Timothy J. Kinsella, & David A. Boothman. (1996). Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation. International Journal of Radiation Oncology*Biology*Physics. 36(2). 361–368. 45 indexed citations
19.
Lamond, John P., Meizhi Wang, Timothy J. Kinsella, & David A. Boothman. (1996). Radiation lethality enhancement with 9-aminocamptothecin: Comparison to other topoisomerase I inhibitors. International Journal of Radiation Oncology*Biology*Physics. 36(2). 369–376. 31 indexed citations
20.
Auchter, R M, John P. Lamond, E Alexander, et al.. (1995). 8 A multi-institutional outcome and prognostic factor analysis of radiosurgery (RS) for resectable single brain metastasis. International Journal of Radiation Oncology*Biology*Physics. 32. 145–145. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026